scAAV9 gene therapy(Abeona Therapeutics)
N/A
Report date: 2025/01/26 17:58:05
Base Information
Drug NamescAAV9 gene therapy(Abeona Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeona Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of North Carolina, Greensboro
Inactive CompaniesAbeona Therapeutics Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A